Atrás
36
Rango del Día
$43.01
$47.55
Rango de 52 Semanas
$23.30
$57.88
Volumen
1,450,684
Promedio 50D / 200D
$45.44
/
$34.84
Cierre Anterior
$44.50
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -37.5 | 0.3 |
| P/B | 6.2 | 2.9 |
| ROE % | -16.4 | 3.7 |
| Net Margin % | -20.6 | 3.8 |
| Rev Growth 5Y % | 29.9 | 10.0 |
| D/E | 0.3 | 0.2 |
Precio Objetivo de Analistas
Hold
$48.25
+1.6%
Low: $41.00
High: $52.00
EPS Futuro
-$1.81
Ingresos Est.
440 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.25
$1.23 – $1.26
|
760 M | 2 |
| FY2029 |
$0.50
$0.49 – $0.50
|
660 M | 3 |
| FY2028 |
-$0.60
-$1.32 – $0.14
|
580 M | 6 |
Puntos Clave
Revenue grew 29.88% annually over 5 years — strong growth
Debt/Equity of 0.29 — conservative balance sheet
Negative free cash flow of -75.63M
PEG of 0.34 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 9.56%
Capital efficient — spends only 7.44% of revenue on capex
Crecimiento
Revenue Growth (5Y)
29.88%
Revenue (1Y)20.32%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-16.43%
ROIC-16.75%
Net Margin-20.63%
Op. Margin-36.18%
Seguridad
Debt / Equity
0.29
Current Ratio3.64
Interest Coverage0.00
Valoración
P/E Ratio
-37.49
P/B Ratio6.16
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20.32% | Revenue Growth (3Y) | 23.95% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 29.88% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 376.57M | Net Income (TTM) | -77.67M |
| ROE | -16.43% | ROA | -12.10% |
| Gross Margin | 50.72% | Operating Margin | -36.18% |
| Net Margin | -20.63% | Free Cash Flow (TTM) | -75.63M |
| ROIC | -16.75% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.29 | Current Ratio | 3.64 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -37.49 | P/B Ratio | 6.16 |
| P/S Ratio | 7.73 | PEG Ratio | 0.34 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.91B | Enterprise Value | 2.87B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 376.57M | 312.97M | 245.11M | 203.57M | 132.33M |
| Net Income | -77.67M | -208.73M | -204.62M | -217.86M | -152.10M |
| EPS (Diluted) | -1.30 | -3.60 | -3.60 | -4.04 | -3.15 |
| Gross Profit | 191.00M | 133.35M | 89.73M | 84.24M | 51.71M |
| Operating Income | -136.26M | -220.83M | -217.16M | -234.78M | -152.73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 641.86M | 614.32M | 776.40M | 961.38M | 702.10M |
| Total Liabilities | 168.90M | 141.63M | 152.97M | 171.99M | 121.28M |
| Shareholders' Equity | 472.96M | 472.69M | 623.43M | 789.39M | 580.82M |
| Total Debt | 137.32M | 85.03M | 94.07M | 94.91M | 62.92M |
| Cash & Equivalents | 183.05M | 226.32M | 286.47M | 378.69M | 465.83M |
| Current Assets | 332.97M | 346.78M | 424.26M | 596.48M | 546.50M |
| Current Liabilities | 91.41M | 71.01M | 73.32M | 90.66M | 63.05M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#94 of 147
Actividad Reciente
Entró
Full Throttle
Mar 24, 2026